James R. Mason

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

Philippe Armand, Arnon Nagler, Edie Weller et al. · Journal of Clinical Oncology · 2013 · 437 citations · Full text

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

Asad Bashey, Bridget Medina, Sue Corringham et al. · Blood · 2008 · 364 citations · Full text

Thallium scintigraphy during dobutamine infusion: Nonexercise-dependent screening test for coronary disease

James R. Mason, Robert T. Palac, Maynard L. Freeman et al. · American Heart Journal · 1984 · 144 citations

Coronary Disease, Cardiovascular Disease, Thallium Scintigraphy +6

Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma

Mohamad A. Hussein, Mansoor N. Saleh, Farhad Ravandi et al. · British Journal of Haematology · 2004 · 115 citations · Full text

Immunology, Pathology, Cell Death +17

Phase II Multicenter Study of Arsenic Trioxide in Patients With Myelodysplastic Syndromes

Gary J. Schiller, James L. Slack, John D. Hainsworth et al. · Journal of Clinical Oncology · 2006 · 106 citations · Full text